Palaniyandi Manivasakam

This inventor holds 8 USPTO granted patents and 7 published patent applications and 2 EPO patents. Top assignees: Combinatorx, Incorporated, Zalicus, Inc., Indus Pharmaceuticals, Inc.. Active years: 2005-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Palaniyandi Manivasakam. Retrieved from https://idiyas.com/inventor/palaniyandi-manivasakam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 7)

% Patents Active = 12.5

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 6.6

ph-index = 4

Forward Citations = 121(Granted Patents)

Location History:

Brighton, MA (US) (2005 - 2010)
West Roxbury, MA (US) (2011 - 2017)

Company Filing History:

5 out of 10

Combinatorx, Incorporated

Indus Pharmaceuticals, Inc.

patent

Years Active: 2005-2017

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9744175 - Compositions of combinations of non-covalent DNA binding agents and anti-cancer and/or anti-inflammatory agents and their use in disease treatment (2017-08-29),

2. 8080553 - Methods and reagents for the treatment of immunoinflammatory disorders (2011-12-20),

3. 7915265 - Combinations for the treatment of immunoinflammatory disorders (2011-03-29),

4. 7709495 - Methods and reagents for the treatment of inflammatory disorders (2010-05-04),

5. 7335371 - Combinations for the treatment of inflammatory disorders (2008-02-26),

6. 7253155 - Combinations for the treatment of immunoinflammatory disorders (2007-08-07),

7. 6955815 - Combinations for the treatment of inflammatory disorders (2005-10-18),

8. 6897206 - Combinations for the treatment of inflammatory disorders (2005-05-24),

Title: The Innovative Contributions of Palaniyandi Manivasakam

Introduction

Palaniyandi Manivasakam is a notable inventor based in Brighton, MA (US). He has made significant contributions to the field of medical science, particularly in the development of treatments for cancer and inflammatory disorders. With a total of 8 patents to his name, his work continues to impact the healthcare industry.

Latest Patents

Among his latest patents, one invention focuses on compositions of combinations of non-covalent DNA binding agents and anti-cancer and/or anti-inflammatory agents. This invention provides compositions for treating cancer or inflammatory disorders, comprising a combination of agents in a pharmaceutically acceptable carrier. The agents include a non-covalent DNA binding agent and an anti-cancer or anti-inflammatory agent. Another significant patent features methods and reagents for the treatment of immunoinflammatory disorders. This invention outlines a method for treating patients diagnosed with, or at risk of developing, an immunoinflammatory disorder by administering a tetra-substituted pyrimidopyrimidine, either alone or in combination with additional agents.

Career Highlights

Throughout his career, Palaniyandi has worked with various companies, including Combinatorx, Incorporated and Zalicus, Inc. His innovative approaches and research have contributed to advancements in therapeutic treatments.

Collaborations

Palaniyandi has collaborated with notable individuals in his field, including Edward Roydon Jost-Price and Nicole Hurst. These collaborations have further enhanced the impact of his inventions.

Conclusion

Palaniyandi Manivasakam's contributions to medical science through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for innovative treatments in healthcare.

Profile summary based on public USPTO records.